Stages II-III Bladder Cancer

Votrient® plus Taxol® Promising in Relapsed and Refractory Bladder Cancer (03-30-2015)

The treatment combination of Votrient® (pazopanib) plus Taxol® (paclitaxel) appears active against bladder cancer that has not responded to or come back after previous therapy. These findings were presented at the 2015 Genitourinary Cancers Symposium... Continue Reading

Studies Evaluate Robot Assisted Cystectomy Treatment of Bladder Cancer (07-29-2014)

The bladder is a hollow organ located in the pelvis. Its primary function is to store urine. The bladder has a muscular wall that allows it to get larger and smaller as urine is stored or emptied. Bladder cancer is diagnosed in roughly 50,000 men and... Continue Reading

Survival Benefit with Immediate Adjuvant Chemotherapy in Invasive Bladder Cancer (06-23-2014)

Results from a recent Phase III clinical trial suggest that patients with invasive bladder cancer may benefit from treatment with immediate adjuvant chemotherapy. These finding were presented at the 2014 American Society of Clinical Oncology (ASCO) meeting... Continue Reading

Immediate Cisplatin-Based Chemotherapy Extends Progression-Free Survival in Invasive Bladder Cancer (06-17-2014)

A report at the 2014 American Society of Clinical Oncologists meeting indicates that immediate use of cisplatin-based chemotherapy offers significant improvement in progression-free survival over deferred treatment in invasive bladder cancer patients.... Continue Reading

Robotic Bladder Cancer Surgery Safe and Effective (01-24-2013)

Robotic-assisted surgery for invasive bladder cancer is effective and results in less bleeding and shorter hospital stays when compared to the traditional open procedure, according to the results of a study published in the Journal of Urology. The bladder... Continue Reading

Adding Chemotherapy to Radiation Reduces Bladder Cancer Recurrence (04-30-2012)

Chemotherapy plus radiation reduces the risk of recurrence in muscle-invasive bladder cancer patients by nearly 50% compared to radiation alone, according to the results of a study published in the New England Journal of Medicine.[1] Bladder cancer is... Continue Reading

Study Explores New Approach to Boosting the Immune System after Cancer Treatment (08-24-2011)

Researchers are seeking participants for a Phase II clinical trial that will explore whether an investigational treatment can help the immune system recover after cancer treatment. Cancer treatments such as chemotherapy and radiation therapy often deplete... Continue Reading

Liposomal Cisplatin Safe for Patients with Renal Insufficiency (06-14-2011)

Liposomal cisplatin (Nanoplatin®), a chemotherapy drug still in clinical trials, does not cause damage to the kidneys and appears to provide at least equal anti-cancer effects as cisplatin (Platinol®) among cancer patients with renal insufficiency.... Continue Reading

New Bladder-preserving Therapy Promising in Bladder Cancer (11-9-2010)

A new bladder-preserving approach to treatment of locally invasive bladder cancer appears promising, both for patients for whom radical cystectomy is indicated and for those previously ineligible for curative treatment. These findings were recently published... Continue Reading

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (08-9-2010)

A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment for these diseases. These findings were recently... Continue Reading

Next Page »